Switzerland: 400 Basel residents can legally consume cannabis
The city of Basel will be the first Swiss city to allow some of its residents to legally use cannabis. Starting at the end of the summer, 400 Basel residents will be able to buy cannabis flowers and resin at pharmacies, even though cannabis remains a «illegal substance» within the country. This special exemption will last two and a half years.
The cannabis will be supplied by Pure Production, a company based in the canton of Aargau in northern Switzerland. It has held a government research permit since 2020.
In this German-speaking city, participants must be of legal age, use cannabis regularly, and reside in Basel. The authorities are looking for «average» users. They must also agree to be monitored by doctors. This authorization to use cannabis legally is, in fact, a full-scale scientific study.
That is the whole purpose of a pilot project approved by the Swiss government in April 2021. A political soap opera that has been in effect since 2016. The authorities want to observe « »The Effects of Regulated Cannabis Sales on the Consumption Behavior and Health of Cannabis Users", states the canton of Basel-Stadt in a press release. The 400 participants will therefore serve as test subjects for this study.
A «basis for discussion» for future legalization
The authorities are therefore not giving people carte blanche to use cannabis with complete peace of mind. On the contrary, users will be closely monitored. They « will be regularly surveyed about their cannabis use and their physical and mental health« .
Following Basel’s lead, other Swiss cities are considering launching their own pilot programs. Geneva, the country’s economic capital, as well as Zurich, the second-largest city, could follow suit. If these studies prove successful, the federal government could consider legalizing cannabis nationwide. « »These findings should help lay a solid foundation for a discussion on responsible cannabis policy in Switzerland.", ", the canton continues.
The country is already a leader in cannabis regulation. In terms of health, the medical use of the plant is authorized on a case-by-case basis. As for hemp and CBD, Switzerland allows the sale of varieties containing up to 1 % of THC. This is for now the highest rate in Europe, where other countries on the continent set the limit between 0.3 % and 0.6%.
-
Cannabis in Quebec3 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in New Zealand3 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep
-
Cannabis in France4 weeks ago
Dr. Pascal Douek, a tireless advocate for medical cannabis in France, has died
-
Cannabis in France4 weeks ago
Medical cannabis: The Greens introduce two amendments to accelerate its widespread adoption
-
Cannabis in Canada4 weeks ago
A Canadian study reveals the pleasant psychotropic effects of high-dose CBD
-
Studies on cannabis4 weeks ago
More THC, barely any additional effects: A new study challenges common assumptions about the potency of cannabis
-
Cannabis in Argentina3 weeks ago
The Argentine province of Chubut is creating its own framework for medical cannabis
-
Cannabis in France3 weeks ago
Medical Cannabis: Patients Issue a Formal Notice to the Government to Break the Deadlock


You must be logged in to post a comment Login